Location History:
- Shanghai, CN (2013 - 2014)
- Singapore, SG (2013 - 2017)
Company Filing History:
13 out of 73 
1 out of 1 Years Active: 2013-2017
Title: Innovations and Contributions of Inventor Fang He
Introduction
Fang He is a prominent inventor based in Singapore, known for his significant contributions to the field of vaccine development. With a total of 13 patents to his name, he has made remarkable strides in addressing influenza viruses through innovative research and technology.
Latest Patents
Fang He's latest patents include a monovalent H5 vaccine, which focuses on the development of a vaccine strain using hemagglutinin (HA) engineering to elicit cross-clade protection against H5N1. This invention also encompasses an epitope-chimeric H5 and a reverse genetics influenza virus expressing this chimeric H5. Another notable patent involves monoclonal antibodies targeting neutralizing epitopes on H7 influenza viruses. This invention relates to murine monoclonal antibodies (mAb) 11B9 and 62, which target major neutralizing epitopes of influenza A H7 hemagglutinin. It also includes methods and compositions for the prophylaxis and treatment of H7 influenza using these antibodies.
Career Highlights
Fang He has worked with esteemed organizations such as Temasek Life Sciences Laboratory Limited and Temasek Life Sciences Laboratories Limited. His work in these institutions has been pivotal in advancing research in virology and immunology.
Collaborations
Fang He has collaborated with notable colleagues, including Hwei-Sing Jimmy Kwang and Hong Liang Qian, who have contributed to his research endeavors.
Conclusion
Fang He’s innovative work in vaccine development and his numerous patents highlight his significant impact on public health and the scientific community. His contributions continue to pave the way for advancements in the fight against influenza viruses.